Kintor Pharmaceutical Ltd 2025 Annual Report
Company: Kintor Pharmaceutical Ltd
Sector: Manufacturing
Country: China
Year: 2025
Type: Annual Report
Pages: 290
The report describes a major 2025 transformation toward cosmetics commercialization, with the KOSHINÉ brand achieving year-over-year growth of over 500% and generating RMB32.7 million in revenue from cosmetics products and raw materials. It also records significant clinical progress for the KX-826 and GT20029 pipeline products and reports a workforce of 123 full-time employees. The report includes a disclaimer of opinion on the consolidated financial statements because multiple uncertainties may affect the Group's ability to continue as a going concern.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.